Breast Cancer Update .com - Meet The Professors 2004 Vol2, Issue 2

You are here: Home: Meet The Professors Vol. 2 2004: Faculty and Affiliations

Faculty and Affiliations

	Richard M Elledge, MD Medical Director, Breast Care Center Associate Professor of Medicine, Baylor College of Medicine Breast Center Houston, Texas
	Kevin R Fox, MD Director, Rena Rowan Breast Center Associate Professor of Medicine, University of Pennsylvania Cancer Center Philadelphia, Pennsylvania
	Gershon Locker, MD, FACP Kellogg Scallion Chair of Oncology, Evanston Northwestern Healthcare Professor of Medicine, Northwestern University Feinberg School of Medicine Evanston, Illinois
	Peter M Ravdin, MD, PhD Clinical Professor of Medicine The University of Texas Health Science Center at San Antonio San Antonio, Texas

Community Panel

Thomas Cartwright, MD
US Oncology
Ocala, Florida

Steve Weiss, MD
Northwest Oncology
Coral Springs, Florida

Allan Freedman, MD
Suburban Hematology/
Oncology
Snellville, Georgia

Stephen Grabelsky, MD
Center for Hematology/
Oncology
Boca Raton, Florida

Nikita Shah, MD
MD Anderson Cancer Center
Orlando, Florida

Rajesh Bajaj, MD
Carolina Health Care
Florence, South Carolina

Richard Levine, MD
Space Coast Medical Associates
Titusville, Florida

Greg Favis, MD
Herbert D Kerman Regional
Oncology Center
Daytona Beach, Florida

David Mark Dresdner, MD
St Petersburg, Florida

Howard Abel, MD
Holy Cross Medical Group
Ft Lauderdale, Florida

Gracy Joshua, MD
Lake Worth, Florida

FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:


Richard M Elledge, MD	Grants/Research Support: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc Honorarium: AstraZeneca Pharmaceuticals LP
Kevin R Fox, MD	No financial interests or affiliations to disclose
Gershon Locker, MD, FACP	Grants/Research Support: AstraZeneca Pharmaceuticals LP Consultant and Honorarium: AstraZeneca Pharmaceuticals LP, Sanofi- Synthelabo Inc
Peter M Ravdin, MD, PhD	Grants/Research Support: AstraZeneca Pharmaceuticals LP Consultant: Aventis Pharmaceuticals Inc

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

Table of Contents

Top of Page

Home · Search

Editor's Note

Case 1: A 62-year-old woman with ER/PR-positive, HER2-negative, nodenegative multicentric breast cancer (from the practice of Thomas Cartwright, MD)

- Select publications

Case 2: A 54-year-old woman seven years after node-positive (6/18),ER-positive, PR-negative infiltrating ductal carcinoma with osteoporosis and postchemotherapy pancytopenia (from the practice of AllanFreedman, MD)

- Select publications

Case 3: A 79-year-old woman with ER-positive, PR-negative, HER2-negative metastatic lobular breast cancer and malignant ascites (from the practice of Steven Weiss, MD)

- Select publications

Case 4: A 79-year-old woman presenting with a palpable five-centimeter nodepositive (7/10), ER/PR-positive lobular carcinoma (from the practice of Howard Abel, MD)

- Select publications